Skip to main content

RD74 (Morphine Sulfate Extended-Release 200 mg)

Pill with imprint RD74 is Green, Elliptical/Oval and has been identified as Morphine Sulfate Extended-Release 200 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 200 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for RD74

Morphine Sulfate Extended-Release

Imprint
RD74
Strength
200 mg
Color
Green
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Ranbaxy Pharmaceuticals Inc.
National Drug Code (NDC)
63304-0453
Inactive Ingredients
silicon dioxide, lactose monohydrate, magnesium stearate, stearic acid, magnesium silicate, titanium dioxide, FD&C Blue No. 2, polyethylene glycol 400, polyethylene glycol 4000, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.